The increased abundance of GSK3α in AD in proteomics data is most likely explained by the higher proportion of neuronal phospho-tau pathology in AD compared to CBD and PSP, and higher tau burden compared to PiD. The gene discussed is MTA2; the disease is Alzheimer disease.